Skip to main content
Fig. 6 | European Journal of Medical Research

Fig. 6

From: siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy

Fig. 6

The effect of combining E6-siRNA with Oxaliplatin on CaSki cells migration and metastasis. A. Combination therapy with Oxaliplatin and E6-siRNA after 72 h leads to a significant reduction in the metastatic feature of CaSki cancerous cells compared to the control group. B. The expression of migration-related genes, such as MMP9, in the combination group showed a significant decrease compared to other groups (*p < 0.05, ****p < 0.0001)

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us